The Iqoniko Group has announced a new strategic advisory mandate in the Gulf region, deepening its footprint in the Middle East’s growing health-tech and digital services sector.
In a statement released Tuesday, the Dubai- and London-based firm confirmed it will serve as a strategic advisor to DiabMart, an emerging digital platform headquartered in Dubai that focuses on providing integrated services for people living with diabetes.
DiabMart has positioned itself as the Gulf region’s first specialized diabetes marketplace, offering a comprehensive suite of services through a single mobile application. These include tailored food options, medical consultations, fitness coaching, personalized meal planning, and broader lifestyle support aimed at improving day-to-day management of the condition.
Iqoniko said the partnership will see it guide DiabMart across several strategic areas, including product marketing, brand development, and market positioning. The advisory firm will also play a key role in preparing the company for capital markets engagement, as DiabMart eyes long-term growth and potential investment opportunities.
Speaking on the partnership, Dave Persico highlighted the social and commercial significance of the collaboration, noting the growing global burden of diabetes.
“Diabetes is a widespread condition affecting both children and adults, often fundamentally reshaping daily life,” Persico said. “We are delighted to work with DiabMart to help make life easier for those affected while enhancing their overall quality of life.”
The move reflects a broader trend of increased investment and innovation in digital health platforms across the Gulf, where lifestyle-related diseases such as diabetes remain a major public health concern.
For DiabMart, the partnership is expected to accelerate its expansion strategy, strengthen its brand visibility, and position the company for future participation in capital markets. Iqoniko’s expertise in fundraising, stock exchange listings, and strategic investor positioning is seen as a critical asset as the platform scales its operations.
The Iqoniko Group operates as an international advisory firm specializing in capital markets strategy, supporting startups, listed companies, and investment firms through processes such as going-public transactions, fundraising, and long-term investor alignment.
With offices in Dubai and London, the firm has increasingly positioned itself as a bridge between emerging market innovators and global capital.
The DiabMart mandate marks another step in Iqoniko’s strategy to support high-growth, impact-driven companies, particularly in sectors where technology intersects with healthcare and everyday living.
